Riskpilot← Back to searchSign inGet full accessin2cure AB
ABActiveOrg 5569461493Scheelevägen 2General medical practice activities · NACE 8621Est. 20130 employees
Revenue 2024
SEK 0
EBITDA margin
—
-634% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
SEK -808K
-924% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -884K | -634% |
| Net profit | SEK -808K | -924% |
| Total assets | SEK 5,2M | -17% |
| Equity | SEK 5,2M | -13% |
| Employees | 0 | — |
Legal name
in2cure AB
Org number
5569461493
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 oktober 2013
Share capital
SEK 66 700
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Jensen, Johan Mikael i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva medicinsk forskning och utveckling, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Scheelevägen 2
Email
artur.schmidtchen@in2cure.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 1 662 | 546 | 0 | 0 | 0 | 823 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | — | — | — | −487 | −4 600 | −3 544 | −144 | −78 | −120 | −884 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — | — |
| EBIT | 0 | 0 | 0 | −487 | −4 600 | −3 544 | −144 | −78 | −120 | −884 |
| Net financials | — | — | — | — | — | — | — | 5 850 | 42 | 76 |
| Profit before tax | 0 | 0 | 0 | −487 | −4 600 | −3 544 | −144 | 5 772 | −79 | −808 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — | — |
| Net profit | 0 | 0 | 0 | −487 | −4 600 | −3 544 | −144 | 5 772 | −79 | −808 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 305 | 713 | 729 | 9 315 | 4 497 | 437 | 292 | 6 700 | 6 272 | 5 181 |
| Equity | 50 | 50 | 51 | 8 581 | 3 981 | 437 | 292 | 6 064 | 5 986 | 5 178 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 255 | 663 | 678 | 734 | 516 | 0 | 0 | 636 | 286 | 3 |
| Total debt | 255 | 663 | 678 | 734 | 516 | — | — | 636 | 286 | 3 |
EBITDA margin
-88386400.0%
This company
15.8%
Market median
-559407695% vs market
20152024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20152024
Return on equity
-15.6%
This company
18.4%
Market median
-185% vs market
20152024
Net profit margin
-80781200.0%
This company
8.1%
Market median
-997298865% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
BU | Audit | 2020 | — | — |
LJ Auditor Substitute | Auditor Substitute | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of in2cure AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Helene Lilian Hartman | Chief Executive Officer | 0 companies |
| Bertil Ulf Moritz Raue | Audit | 0 companies |
| Lars Joakim Leifland | Auditor Substitute | 0 companies |
| Bo Ture David Benell | Chairman | 0 companies |
| Eva Marie Mannerlöf | Board of Directors | 0 companies |
| Lena Mårtensson Wernrud | Board of Directors | 0 companies |
| Johan Mikael Jensen | Board of Directors | 0 companies |
| Artur Schmidtchen | Board of Directors | 0 companies |